Using the Ending Self-Stigma Intervention to Reduce Internal... | Clinical Trial | StuddyBuddy@endsection Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT05704764

Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances

Conditions: HIV, Opioid Use, Cocaine Use, Stigma, Social

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 70
Sponsor: Friends Research Institute, Inc.

Location: United States

Summary

The goal of this clinical trial is to test an intervention to reduce stigma among people living with HIV who use opioids and cocaine. The main question it aims to answer is:- Does reducing internalized stigma about HIV and/or drug use lead to improved HIV care outcomes?After a year spent adapting an existing intervention to be applied specifically among people living with HIV who use substances, 70 participants will be randomized to receive either treatment-as-usual or the newly adapted intervention. The intervention itself will consist of less than ten group-based meetings to discuss and work through the stigmas people commonly associate with HIV and/or drug use.

Eligibility Criteria

Inclusion Criteria:18+ years of ageEnglish speakingLiving with HIVScreen positive for opioid use disorder and/or cocaine use disorder on the Composite International Diagnostic InterviewWilling and able to provide full informed consentResponds affirmatively to having ever experienced one or more of the following types of stigma related to HIV status or SU: (1) enacted, (2) anticipated, and/or internalized.Exclusion Criteria:Does not meet all inclusion criteria.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05704764). StuddyBuddy aggregates publicly available trial information.